MCM
HCAT icon

Moore Capital Management’s Health Catalyst HCAT Stock Holding History

Moore Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-398,857
Closed -$1.14M – 738
2025
Q3 		$1.14M Buy
398,857
+226,023
+131% +$774K 0.02% 406
2025
Q2 		$652K Sell
172,834
-45,500
-21% -$179K 0.01% 412
2025
Q1 		$989K Buy
+218,334
New +$1.16M 0.02% 320

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moore Capital Management's HCAT Position: Q4 2025 in Review

Moore Capital Management sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 398,857 shares — an estimated $1.14M sold.

Moore Capital Management first reported a position in HCAT in Q1 2025 and held it in 3 quarters. The position peaked at $1.14M in Q3 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Moore Capital Management reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Moore Capital Management sold 398,857 Health Catalyst shares in Q4 2025, an estimated $1.14M.
  • Moore Capital Management first reported a position in Health Catalyst in Q1 2025 and held it in 3 quarters.
  • Moore Capital Management's Health Catalyst position peaked at $1.14M in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Moore Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.